product information:


name:PtCu Nanozyme


Product performance: PtCu nanoenzyme treatment can significantly inhibit the diffusion of α-synuclein from the striatum to the substantia nigra. It provides a new strategy for the application of nanozymes in the treatment of PD diseases.

Application field: The application of PtCunanozyme in preventing α-synuclein is expected to provide reference for the treatment and prevention of other neurodegenerative diseases such as Alzheimers disease.